Variant report
Variant | nsv875516 |
---|---|
Chromosome Location | chr2:186031490-186124709 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:13)
- LncRNA region (count:33)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:186100441..186101971-chr2:186105375..186108257,2 | K562 | blood: | |
2 | chr2:186100441..186101971-chr2:186105375..186108257,2 | K562 | blood: | |
3 | chr2:186094342..186094913-chr2:186257717..186258552,2 | MCF-7 | breast: | |
4 | chr2:186072741..186073624-chr2:186144398..186145591,5 | MCF-7 | breast: | |
5 | chr2:186072660..186073262-chr2:186144866..186145404,2 | MCF-7 | breast: | |
6 | chr2:186077443..186080113-chr2:186084323..186086663,2 | K562 | blood: | |
7 | chr2:186093080..186095459-chr2:186142189..186144036,2 | K562 | blood: | |
8 | chr2:186077443..186080113-chr2:186084323..186086663,2 | K562 | blood: | |
9 | chr2:186088774..186091590-chr2:186093895..186096309,2 | MCF-7 | breast: | |
10 | chr2:186088774..186091590-chr2:186093895..186096309,2 | MCF-7 | breast: | |
11 | chr2:186075062..186075812-chr2:186144515..186145151,2 | MCF-7 | breast: | |
12 | chr2:186072842..186073669-chr2:186603334..186604037,3 | MCF-7 | breast: | |
13 | chr2:186069210..186070750-chr2:186136891..186138828,2 | MCF-7 | breast: |
(count:33 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZSWIM2-7 | chr2:186031578-186031663 | XLOC_002424 |
2 | lnc-ZNF804A-1 | chr2:186031529-186031553 | XLOC_001780 |
3 | lnc-ZNF804A-1 | chr2:186031789-186031910 | XLOC_001780 |
4 | lnc-ZNF804A-1 | chr2:186061344-186061492 | XLOC_001780 |
5 | lnc-ZNF804A-1 | chr2:186031789-186031910 | XLOC_001780 |
6 | lnc-ZNF804A-1 | chr2:186084780-186085106 | XLOC_001780 |
7 | lnc-ZSWIM2-7 | chr2:186031776-186031910 | XLOC_002424 |
8 | lnc-ZNF804A-1 | chr2:186084381-186084458 | XLOC_001780 |
9 | lnc-ZSWIM2-7 | chr2:186031578-186031663 | XLOC_002424 |
10 | lnc-ZNF804A-1 | chr2:186061344-186061503 | XLOC_001780 |
11 | lnc-ZNF804A-1 | chr2:186061344-186061492 | XLOC_001780 |
12 | lnc-ZNF804A-1 | chr2:186031789-186031910 | XLOC_001780 |
13 | lnc-ZNF804A-1 | chr2:186031549-186031553 | XLOC_001780 |
14 | lnc-ZNF804A-1 | chr2:186031549-186031553 | XLOC_001780 |
15 | lnc-ZNF804A-1 | chr2:186031789-186031910 | NONHSAT075957 |
16 | lnc-ZNF804A-1 | chr2:186084381-186084458 | XLOC_001780 |
17 | lnc-ZNF804A-1 | chr2:186031561-186031590 | XLOC_001780 |
18 | lnc-ZNF804A-1 | chr2:186084381-186084653 | XLOC_001780 |
19 | lnc-ZNF804A-1 | chr2:186061470-186061492 | XLOC_001780 |
20 | lnc-ZNF804A-1 | chr2:186084780-186085058 | XLOC_001780 |
21 | lnc-ZNF804A-1 | chr2:186084780-186085058 | XLOC_001780 |
22 | lnc-ZNF804A-1 | chr2:186084381-186084458 | XLOC_001780 |
23 | lnc-ZNF804A-1 | chr2:186031533-186031553 | NONHSAT075957 |
24 | lnc-ZSWIM2-7 | chr2:186031578-186031663 | XLOC_002424 |
25 | lnc-ZNF804A-1 | chr2:186084780-186084990 | XLOC_001780 |
26 | lnc-ZSWIM2-7 | chr2:186031776-186031907 | XLOC_002424 |
27 | lnc-ZNF804A-1 | chr2:186061344-186061631 | NONHSAT075957 |
28 | lnc-ZSWIM2-7 | chr2:186031776-186031910 | XLOC_002424 |
29 | lnc-ZNF804A-1 | chr2:186084780-186084990 | XLOC_001780 |
30 | lnc-ZNF804A-1 | chr2:186031776-186031910 | XLOC_001780 |
31 | lnc-ZNF804A-1 | chr2:186084381-186084458 | XLOC_001780 |
32 | lnc-ZNF804A-1 | chr2:186084381-186084458 | XLOC_001780 |
33 | lnc-ZNF804A-1 | chr2:186031789-186031910 | XLOC_001780 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000226747 | chromatin interactions |
ENSG00000188738 | chromatin interactions |
RNF160 | miRNA target sites |
CTSC | miRNA target sites |
PALLD | miRNA target sites |
HMOX1 | miRNA target sites |
CTSA | miRNA target sites |
KDELC1 | miRNA target sites |
KIF5A | miRNA target sites |
KIT | miRNA target sites |
VBP1 | miRNA target sites |
TGFBR1 | miRNA target sites |
SRPK2 | miRNA target sites |
PAN3 | miRNA target sites |
PTPN1 | miRNA target sites |
DNAJB1 | miRNA target sites |
RPS6KA5 | miRNA target sites |
USF2 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139867048 | chr2:186031538-186031539 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs189934561 | chr2:186031562-186031563 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs573874499 | chr2:186031573-186031574 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs182505254 | chr2:186031609-186031610 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs6704753 | chr2:186031626-186031627 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs566118028 | chr2:186031644-186031645 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs550705309 | chr2:186031785-186031786 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs116312316 | chr2:186031788-186031789 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs145384352 | chr2:186031806-186031807 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs551351793 | chr2:186031829-186031830 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs566746080 | chr2:186031842-186031843 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs562582468 | chr2:186031868-186031869 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs78967611 | chr2:186049411-186049412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570721742 | chr2:186049430-186049431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145468708 | chr2:186049439-186049440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555510389 | chr2:186049593-186049594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141395179 | chr2:186049598-186049599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565507246 | chr2:186049609-186049610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536228626 | chr2:186049665-186049666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554297821 | chr2:186049678-186049679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369123258 | chr2:186049698-186049699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573869662 | chr2:186049707-186049708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs36038835 | chr2:186049716-186049717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534858268 | chr2:186049720-186049721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs60466570 | chr2:186049723-186049724 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs577131775 | chr2:186049730-186049731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541130071 | chr2:186049762-186049763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13007667 | chr2:186049767-186049768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185778893 | chr2:186049796-186049797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190218035 | chr2:186049866-186049867 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147010889 | chr2:186049875-186049876 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75306434 | chr2:186049876-186049877 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531072119 | chr2:186049895-186049896 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138238641 | chr2:186049913-186049914 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530338706 | chr2:186049917-186049918 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528701405 | chr2:186049919-186049920 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546914399 | chr2:186049959-186049960 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs6724681 | chr2:186049966-186049967 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs536008375 | chr2:186049969-186049970 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548167135 | chr2:186049977-186049978 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
41 | rs115426812 | chr2:186050009-186050010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537313198 | chr2:186050034-186050035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558906156 | chr2:186050059-186050060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577242819 | chr2:186050127-186050128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76108712 | chr2:186050186-186050187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552935777 | chr2:186050210-186050211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548918398 | chr2:186050288-186050289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574869003 | chr2:186050290-186050291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs180848137 | chr2:186050306-186050307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185065507 | chr2:186050345-186050346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186049400-186049800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr2:186049800-186050000 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr2:186050000-186053200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr2:186053000-186053400 | Enhancers | Fetal Kidney | kidney |
5 | chr2:186053200-186053400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr2:186063200-186063600 | Enhancers | HSMM | muscle |
7 | chr2:186070800-186071000 | Enhancers | Pancreas | Pancrea |
8 | chr2:186073000-186073400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr2:186080000-186080400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr2:186080200-186080400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr2:186083200-186085800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr2:186084000-186085200 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr2:186084000-186085200 | Enhancers | HSMM | muscle |
14 | chr2:186084200-186084600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr2:186084600-186085200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr2:186087200-186087400 | Enhancers | Muscle Satellite Cultured Cells | -- |
17 | chr2:186105600-186106200 | Enhancers | Fetal Brain Female | brain |
18 | chr2:186110600-186111000 | Enhancers | Fetal Heart | heart |
19 | chr2:186119400-186121000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
20 | chr2:186124200-186124400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr2:186124400-186129400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |